| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Provision for doubtful accounts, net | NaN | NaN | NaN | -139 |
| Net loss | -487 | -4,942 | -13,736 | -7,406 |
| Non-cash interest expense | NaN | 0 | 20 | 8 |
| Net loss from discontinued operations | NaN | NaN | -17,864 | NaN |
| Gain on sale of marketable securities | NaN | NaN | 0 | 0 |
| Amortization of right-of-use assets | 173 | 52 | 61 | 143 |
| Loss on disposal of assets | NaN | -11,143 | NaN | NaN |
| Share-based compensation expense | 0 | 13 | 22 | 44 |
| Change of inventory to net realizable value | NaN | NaN | NaN | 320 |
| Inventories | -20 | 2,306 | NaN | -2,345 |
| Receivables | NaN | NaN | NaN | -1,293 |
| Income taxes receivable | NaN | NaN | NaN | -19 |
| Prepaid expenses and other assets | -219 | NaN | NaN | 229 |
| Deferred product revenue | NaN | NaN | NaN | -5 |
| Accounts payable | 34 | -88 | -182 | 224 |
| Accrued liabilities | -234 | 468 | -937 | 758 |
| Operating lease liabilities | -176 | -53 | -61 | -144 |
| Net cash used in operating activities, continuing operations | -680 | -11,232 | -3,322 | NaN |
| Purchase of property and equipment | NaN | NaN | 0 | 17 |
| Depreciation and amortization expense | NaN | NaN | NaN | 248 |
| Purchase of intangibles | NaN | NaN | 0 | 16 |
| Gain on sale of capitalized assets | NaN | NaN | NaN | 9 |
| Proceeds from sale of capitalized assets | NaN | NaN | 0 | 12 |
| Net cash used in operating activities | NaN | NaN | NaN | -2,568 |
| Net cash provided by (used in) investing activities | NaN | NaN | NaN | -21 |
| Proceeds from maturities and sales of marketable securities | NaN | 0 | 0 | 0 |
| Proceeds from issuance of convertible note | NaN | 0 | 0 | 3,000 |
| Purchases of marketable securities | NaN | 0 | 0 | 0 |
| Cash provided by (used in) operating activities, discontinued operations | -733 | 8,279 | -1,247 | NaN |
| Net proceeds from equity-based compensation programs | NaN | NaN | 0 | 0 |
| Net cash provided by investing activities, continuing operations | 0 | 21 | -21 | NaN |
| Dividend payment | NaN | 0 | 0 | 0 |
| Cash used in investing activities, discontinued operations | 0 | 2,912 | 0 | NaN |
| Proceeds from sale of stock | 1,750 | 0 | 0 | 1,000 |
| Purchases of outstanding warrants | 22 | -1 | 34 | NaN |
| Proceeds from equity-based compensation programs | NaN | -1 | NaN | NaN |
| Net cash provided by financing activities, continuing operations | 1,728 | 0 | 3,966 | NaN |
| Cash provided by financing activities, discontinued operations | 0 | 0 | 0 | NaN |
| Net cash provided by discontinued operations | NaN | 11,191 | -1,247 | NaN |
| Effect of exchange rate changes on cash and cash equivalents | -1 | -5 | -29 | NaN |
| Net cash provided by (used in) financing activities | NaN | NaN | NaN | 4,000 |
| Net increase (decrease) in cash and cash equivalents | 314 | -25 | -653 | NaN |
| Effect of exchange rate changes on cash and cash equivalents | NaN | NaN | NaN | -18 |
| Cash and cash equivalents at the beginning of the period | 739 | 764 | 1,417 | NaN |
| Net increase (decrease) in cash and cash equivalents | NaN | NaN | NaN | 1,393 |
| Cash and cash equivalents at the end of the period | 1,053 | 739 | 764 | NaN |
CLEARONE INC (CLRO)
CLEARONE INC (CLRO)